Anti-cancer
Gemcitabine
Also known as: Gemcitabine Hydrochloride
CAS No.
95058-81-4
A nucleoside analogue antimetabolite used in injectable oncology formulations for pancreatic, lung, breast, and ovarian cancers.
Gemcitabine is a deoxycytidine analogue antimetabolite API manufactured by NovaAcura Biotech under strict GMP conditions appropriate to cytotoxic API handling. The company supplies full batch documentation and regulatory support to global oncology formulation partners.
Applications & Uses
A nucleoside analogue antimetabolite used in injectable oncology formulations for pancreatic, lung, breast, and ovarian cancers.
Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.
Need This Molecule at Scale?
Get in touch for pricing, lead times and full regulatory documentation.
Get In Touch